Asahi Life Asset Management Co., Ltd. Dexcom Inc Transaction History

Asahi Life Asset Management Co., Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$129.87 - $162.82 $62,337 - $78,153	-480 Closed	0 $0
Q3 2021 Oct 29, 2021	BUY	$106.71 - $143.18 $51,220 - $68,726	480 New	480 $262,000
Q3 2020 Nov 02, 2020	SELL	$95.51 - $112.95 $61,126 - $72,288	-640 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$62.68 - $105.34 $40,115 - $67,417	640 New	640 $259,000
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $88,411 - $139,915	-1,850 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$36.62 - $57.29 $67,747 - $105,986	1,850 New	1,850 $405,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Asahi Life Asset Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Asahi Life Asset Management Co., Ltd. with notifications on news.